
Suryoday Small (SURYODAY) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
3.0B
Net Income
-337.8M
-11.08%
Balance Sheet Metrics
Total Assets
156.1B
Total Liabilities
136.9B
Shareholders Equity
19.3B
Debt to Equity
7.10
Cash Flow Metrics
Operating Cash Flow
-604.9M
Free Cash Flow
-7.3B
Revenue & Profitability Trend
Suryoday Small Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 13.2B | 11.8B | 8.4B | 6.8B | 4.9B |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 70.5M | 54.6M | 63.1M | 34.4M |
Other Operating Expenses | 4.9B | 2.5B | 1.7B | 1.2B | 894.3M |
Total Operating Expenses | 4.9B | 2.6B | 1.7B | 1.3B | 928.7M |
Operating Income | - | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | - | - | - | - | - |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 1.4B | 2.9B | 1.0B | -1.3B | 120.9M |
Income Tax | 288.6M | 716.1M | 231.7M | -340.4M | 2.4M |
Effective Tax Rate % | 20.1% | 24.9% | 23.0% | 0.0% | 2.0% |
Net Income | 1.1B | 2.2B | 776.9M | -930.2M | 118.5M |
Net Margin % | 8.7% | 18.3% | 9.2% | -13.7% | 2.4% |
Key Metrics | |||||
EBITDA | - | - | - | - | - |
EPS (Basic) | - | ₹20.34 | ₹7.32 | -₹8.76 | ₹1.32 |
EPS (Diluted) | - | ₹20.15 | ₹7.32 | -₹8.76 | ₹1.31 |
Basic Shares Outstanding | - | 106162703 | 106158749 | 106140544 | 89687586 |
Diluted Shares Outstanding | - | 106162703 | 106158749 | 106140544 | 89687586 |
Income Statement Trend
Suryoday Small Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 17.1B | 11.8B | 8.3B | 9.8B | 5.9B |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | - | - | - | - | - |
Non-Current Assets | |||||
Property, Plant & Equipment | - | 3.0B | 2.6B | 1.2B | 739.8M |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | - | - | - | - | - |
Total Assets | 156.1B | 123.8B | - | - | - |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | - | 859.3M | 494.5M | 217.4M | 184.6M |
Short-term Debt | - | - | - | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | - | - | - | - | - |
Non-Current Liabilities | |||||
Long-term Debt | 27.1B | 17.3B | 20.4B | 18.4B | 16.9B |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - | - |
Total Liabilities | 136.9B | 105.7B | - | - | - |
Equity | |||||
Common Stock | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B |
Retained Earnings | - | 3.2B | 1.5B | 1.1B | 2.1B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 19.3B | 18.0B | 15.8B | 15.1B | 16.0B |
Key Metrics | |||||
Total Debt | 27.1B | 17.3B | 20.4B | 18.4B | 16.9B |
Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Suryoday Small Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | - | - | - | - | - |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 44.5M | 37.6M | 25.3M | 9.3M | 58.7M |
Working Capital Changes | -843.2M | -1.2B | 1.0B | 33.0M | 253.5M |
Operating Cash Flow | 670.5M | 1.8B | 2.3B | -1.2B | 455.0M |
Investing Activities | |||||
Capital Expenditures | -1.8B | -556.5M | -926.2M | -913.4M | -195.0M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -8.8B | -2.7B | -1.8B | -661.4M | - |
Investment Sales | - | 715.0M | 161.9M | 0 | - |
Investing Cash Flow | -10.6B | -2.6B | -2.7B | -1.6B | -199.0M |
Financing Activities | |||||
Share Repurchases | - | - | -6.1M | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | 7.5B | 14.5B | 10.0B |
Debt Repayment | - | - | -5.4B | -5.7B | -5.9B |
Financing Cash Flow | 10.1M | 5.1M | 2.1B | 8.9B | 9.1B |
Free Cash Flow | 11.4B | 8.8B | -1.9B | -4.4B | -9.0B |
Net Change in Cash | -9.9B | -840.7M | 1.8B | 6.1B | 9.4B |
Cash Flow Trend
Suryoday Small Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
13.04
Forward P/E
4.85
Price to Book
0.77
Price to Sales
1.38
Profitability Ratios
Profit Margin
10.67%
Operating Margin
-22.14%
Return on Equity
6.16%
Return on Assets
0.82%
Financial Health
Debt to Equity
1.41
Beta
0.11
Per Share Data
EPS (TTM)
₹10.76
Book Value per Share
₹181.41
Revenue per Share
₹101.45
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
suryoday | 14.9B | 13.04 | 0.77 | 6.16% | 10.67% | 1.41 |
HDFC Bank Limited | 15.3T | 22.62 | 2.91 | 14.57% | 25.95% | 0.74 |
ICICI Bank | 10.2T | 19.96 | 3.22 | 18.23% | 25.43% | 0.71 |
DCB Bank Limited | 46.5B | 7.59 | 0.82 | 11.44% | 23.23% | 1.60 |
Utkarsh Small | 26.1B | 106.41 | 0.78 | 0.80% | 1.44% | 0.79 |
Fino Payments Bank | 23.2B | 25.23 | 3.11 | 13.31% | 5.30% | 1.12 |
Financial data is updated regularly. All figures are in the company's reporting currency.